Patent · US Active

Delta-2-tubulin as a biomarker and therapeutic target for peripheral neuropathy

US11874284B2 · kind B2 · utility

0Cited by

3References

3Claims

0Family size

Assignees

The Trustees of Columbia University in the City of New York · US
UNIVERSITA' DEGLI STUDI DI MILANO - BICOCCA · IT

Inventors

Francesca Bartolini · New York, US
Maria Elena Pero · New York, US
Guido Cavaletti · Monza, IT

Key dates

Filing date	May 27, 2020
Grant date	Jan 16, 2024
Priority date	—
Expiry date	May 27, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to delta-2-tubulin and its use as a biomarker for determining if a subject is at risk of developing peripheral neuropathy or if a subject has developed peripheral neuropathy. The present disclosure further relates to methods for the treatment of peripheral neuropathy in a subject and assays for identifying compounds that can be used to treat and/or prevent peripheral neuropathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.